Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $1.2 in the prior trading day, Werewolf Therapeutics Inc (NASDAQ: HOWL) closed at $1.15, down -4.17%. In other words, the price has decreased by -$4.17 from its previous closing price. On the day, 0.74 million shares were traded. HOWL stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $1.07.
Ratios:
Our goal is to gain a better understanding of HOWL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 3.87. In the meantime, Its Debt-to-Equity ratio is 1.26 whereas as Long-Term Debt/Eq ratio is at 1.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, JMP Securities on April 03, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $12.
On August 24, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 04 ’25 when EVNIN LUKE sold 90,164 shares for $1.22 per share. The transaction valued at 110,000 led to the insider holds 3,853,195 shares of the business.
EVNIN LUKE sold 34,947 shares of HOWL for $42,286 on Nov 06 ’25. The Director now owns 3,787,474 shares after completing the transaction at $1.21 per share. On Nov 05 ’25, another insider, EVNIN LUKE, who serves as the Director of the company, sold 30,774 shares for $1.22 each. As a result, the insider received 37,544 and left with 3,822,421 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOWL now has a Market Capitalization of 55821228 and an Enterprise Value of 27410230.
Stock Price History:
The Beta on a monthly basis for HOWL is 0.74, which has changed by -0.47727275 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, HOWL has reached a high of $2.41, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -28.26%, while the 200-Day Moving Average is calculated to be -9.87%.
Shares Statistics:
The stock has traded on average 782.14K shares per day over the past 3-months and 876410 shares per day over the last 10 days, according to various share statistics. A total of 47.27M shares are outstanding, with a floating share count of 34.39M. Insiders hold about 29.80% of the company’s shares, while institutions hold 32.29% stake in the company. Shares short for HOWL as of 1760486400 were 824144 with a Short Ratio of 1.05, compared to 1757894400 on 822835. Therefore, it implies a Short% of Shares Outstanding of 824144 and a Short% of Float of 2.53.
Earnings Estimates
Werewolf Therapeutics Inc (HOWL) is currently under the scrutiny of 4.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.4 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.51 and -$1.74 for the fiscal current year, implying an average EPS of -$1.57. EPS for the following year is -$1.28, with 4.0 analysts recommending between -$0.8 and -$1.62.
